PAGE Therapeutics AG
Biotechnology · Basel, Basel-Stadt
PAGE Therapeutics AG is a Swiss biotechnology company based in Basel, Canton of Basel-Stadt, listed in the Swiss commercial register since 2022 (UID CHE-430.597.527).
Board members & signatories
- Daniele Scarinci — Präsident des Verwaltungsrates
- Meret Gaugler — Mitglied des Verwaltungsrates
- Christoph Rochlitz — Mitglied des Verwaltungsrates
Registered purpose
Die Gesellschaft bezweckt die Entdeckung, Erforschung, Entwicklung, Herstellung, Verwertung, Erwerb und den Vertrieb von Arzneimitteln. Die Gesellschaft kann alle kommerziellen, vertraglichen und finanziellen Geschäfte eingehen und alle Aktivitäten vornehmen, die geeignet sind, den Zweck der Gesellschaft zu fördern, oder die direkt oder indirekt damit in Zusammenhang stehen. Ferner kann sie Zweign…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What PAGE Therapeutics does
OFFERING
PAGE Therapeutics focuses on oncology drug development, specifically targeting cell-cell adhesion in cancer cells. The company has identified compounds that disrupt these adhesion mechanisms, aiming to block the spread of cancer and improve patient outcomes. Their approach includes a proof of concept clinical trial for breast cancer patients, demonstrating the potential of their therapeutic compounds.
Unlock the full analysis →Similar companies
- TheraPPI Bioscience AG — Biotechnology · Plan-les-Ouates
- MPC Therapeutics AG — Pharmaceuticals · Genève
- CORETAG Therapeutics AG — Pharmaceuticals · Basel
- ADC Therapeutics AG — Biotechnology · Epalinges
- PDC Therapeutics SA — Biotechnology · Epalinges
- Partex.AI Therapeutics AG — Pharmaceuticals · Cham
Find every biotechnology company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned biotechnology companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime